By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novavax, Inc. 

9920 Belward Campus Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-268-2000 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M™ 10/30/2014 10:07:37 AM
Novavax, Inc. (NVAX) To Host Conference Call To Discuss Third Quarter 2014 Financial Results On November 5, 2014 10/30/2014 8:34:01 AM
Novavax, Inc. (NVAX) Announces Ebola Vaccine Development Program At The 8th Vaccine And ISV Conference In Philadelphia 10/27/2014 10:16:50 AM
Novavax, Inc. (NVAX) Presents RSV F Protein Nanoparticle Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26 10/27/2014 10:10:00 AM
Novavax, Inc. (NVAX) To Present RSV Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26 10/24/2014 10:35:10 AM
Novavax, Inc. (NVAX) Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies 10/15/2014 8:00:49 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV Vaccine In Elderly Subjects 10/14/2014 8:03:36 AM
Novavax, Inc. (NVAX) Announces Biomedical Advanced Research and Development Authority (BARDA) Exercise Of Contract Option 9/23/2014 8:25:00 AM
Novavax, Inc. (NVAX)' H7n9 Avian Influenza VLP Vaccine Candidate With Matrix-M™ Delivers Positive Phase 1/2 Clinical Data 9/23/2014 8:21:47 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV F-Protein Nanoparticle Vaccine Candidate In Healthy Third-Trimester Pregnant Women 9/17/2014 7:34:27 AM
12345678910...
//-->